|May 2011 · Vol. 23, No. 5
VSCAN OFFERS QUICK-LOOK IMAGING
OUTSIDE THE ULTRASOUND SCAN ROOM
GE Healthcare’s Vscan is a new, pocket-sized, hand-held ultrasound tool that provides black and white anatomic and color-coded blood flow images. Roughly the size of a smart phone, it is now being used by ObGyns in a clinical setting beyond the ultrasonography room. While Vscan is not intended to replace a full fetal ultrasound survey, it has the potential to redefine regular prenatal exams by providing physicians a quick look to assess fetal viability, says the manufacturer. Vscan can be used during every step of a pregnancy—from fertility procedures through labor and delivery.
FOR MORE INFORMATION, VISIT www.gehealthcare.com/Vscan
MICROLINE SURGICAL’S MISEAL, A NEW
REPOSABLE THERMAL LIGATING SYSTEM
The new MiSeal™ Reposable Thermal Ligating System from Microline Surgical, can seal and divide, grasp and dissect soft tissue and vessels using a reusable handle, dual-action jaw, and disposable tips. Proprietary tissue welding technology uses direct thermal energy and focused pressure, offering the clinical benefits of precision, safety and reliability. MiSeal minimizes instrument exchange and the risk of collateral tissue damage while providing the economical benefits of a reposable design, says Microline.
FOR MORE INFORMATION, VISIT www.microlinesurgical.com
OB COUNSELOR BRINGS TELEMEDICINE
TO OBGYNS AND THEIR PATIENTS
OB Counselor™ sends your gestationally relevant text messages to your patients throughout their pregnancy, bridging the communication gap that occurs between office visits. OB Counselor strengthens doctor-patient relationships and fosters patient education through personalized communication. Edit, delete, or add to customized messages using physician-authored templates, or create your own text with this powerful practice-marketing tool. A better informed patient will be more compliant, have fewer and better-quality questions, and, ultimately, have a better outcome, says Peter G. Levinson, MD, MBA, a partner in OB Counselor. Expected improvement in pregnancy outcomes are currently under study.
FOR MORE INFORMATION, VISIT www.OBCounselor.com
INTERSTIM THERAPY NOW APPROVED
FOR BOWEL CONTROL
Medtronic’s InterStim Therapy is now FDA-approved for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments. It was previously available to treat overactive bladder and urinary retention. The implantable InterStim system delivers mild electrical stimulation to the sacral nerves to influence the behavior of pelvic floor muscles and bowel. In a multi-center clinical trial, InterStim Therapy significantly reduced fecal incontinence episodes for 83% of clinical trial patients, with 41 % of patients experiencing no incontinent episodes, reports Medtronic.
FOR MORE INFORMATION, VISIT www.medtronic.com
OBG Management ©2011 Quadrant HealthCom Inc.